CJC-1295 No DAC

Growth Hormone Research Peptide for GHRH Receptor Signalling & Endocrine Regulation

CJC-1295 No DAC is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH). It has attracted significant scientific interest due to its interaction with GHRH receptors and its role in research investigating growth hormone secretion and endocrine signalling.

Unlike CJC-1295 with DAC, the No DAC version does not contain the Drug Affinity Complex modification responsible for prolonged albumin binding. It is therefore investigated as a shorter-acting GHRH analogue in laboratory models examining pituitary activity, growth hormone regulation and hormonal signalling pathways.

Key Features

✓ Studied for its interaction with GHRH receptor pathways
✓ Frequently researched in growth hormone signalling models
✓ Investigated for its effects on pituitary hormone regulation
✓ Explored in endocrine and hypothalamic signalling research
✓ Studied in growth hormone secretion mechanisms
✓ Relevant to hormonal regulation and endocrine physiology research

GHRH Receptor Research

CJC-1295 No DAC is investigated for its interaction with growth hormone-releasing hormone receptors. These receptors play an important role in regulating growth hormone secretion from the anterior pituitary gland.

Growth Hormone Signalling Research

Researchers study CJC-1295 No DAC in laboratory models examining the biological mechanisms involved in growth hormone release and hormonal signalling.

Pituitary Function Studies

Research explores the relationship between GHRH receptor activation and pituitary activity, particularly the regulation of growth hormone secretion.

Endocrine Regulation Research

CJC-1295 No DAC is investigated in models examining the communication between the hypothalamus and pituitary gland and the hormonal pathways responsible for maintaining endocrine balance.

Scientific Research Context

Growth hormone regulation involves a complex endocrine network connecting the hypothalamus, pituitary gland and peripheral tissues.

Growth hormone-releasing hormone (GHRH) is naturally produced by the hypothalamus and stimulates the anterior pituitary gland to release growth hormone.

CJC-1295 No DAC is a synthetic GHRH analogue developed to investigate these biological pathways. Its structure and receptor activity make it relevant to research examining:

• GHRH receptor signalling
• Growth hormone secretion mechanisms
• Pituitary gland activity
• Hypothalamic signalling pathways
• Endocrine regulation
• Hormonal communication mechanisms
• Growth hormone physiology
• Somatotropic axis research

These research areas continue to contribute to scientific interest in CJC-1295 No DAC and its role in endocrine science.

Common Research Applications

CJC-1295 No DAC is frequently investigated in research models involving:

• Growth hormone-releasing hormone pathways
• GHRH receptor activity
• Pituitary hormone secretion
• Growth hormone signalling
• Hypothalamic regulation
• Endocrine physiology
• Somatotropic axis research
• Hormonal signalling mechanisms

Related Research Compounds

Researchers investigating growth hormone signalling and endocrine pathways may also study:

• CJC-1295 DAC – modified GHRH analogue research involving prolonged albumin binding.
• Ipamorelin – growth hormone secretagogue receptor signalling research.
• GHRP-2 – growth hormone release and ghrelin receptor research.
• GHRP-6 – growth hormone secretagogue and endocrine signalling research.
• Sermorelin – GHRH analogue and pituitary hormone regulation research.

These compounds are investigated through different mechanisms within growth hormone and endocrine science.

Product Specifications

Product Name: CJC-1295 No DAC
Compound Type: Synthetic Peptide
Research Category: Growth Hormone & Endocrine Research
Primary Target: Growth Hormone-Releasing Hormone (GHRH) Receptor
Physical Form: Research Grade Powder
Available Sizes: 2mg, 5mg and 10mg Vials
Application: Scientific Research Use Only

Important Notice

For laboratory research use only. This product is intended solely for research, analytical and educational purposes. It is not intended for human or animal consumption, therapeutic use, veterinary use, diagnostic procedures or administration of any kind.

CJC-1295 No DAC is an experimental research peptide and should not be confused with CJC-1295 DAC. Its safety and efficacy for human use have not been established through adequate clinical research.